Gabriel Fung Selected Research

Coxsackievirus Infections

9/2017	Phosphorylation and degradation of αB-crystallin during enterovirus infection facilitates viral replication and induces viral pathogenesis.
1/2017	Cleavage of Grb2-Associated Binding Protein 2 by Viral Proteinase 2A during Coxsackievirus Infection.
10/2015	Dysferlin deficiency confers increased susceptibility to coxsackievirus-induced cardiomyopathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gabriel Fung Research Topics

Disease

12	Infections 01/2021 - 01/2013
5	Neoplasms (Cancer) 11/2018 - 10/2011
4	Virus Diseases (Viral Diseases) 01/2021 - 09/2014
4	Myocarditis (Carditis) 01/2021 - 10/2015
3	Enterovirus Infections 01/2019 - 07/2015
3	Inflammation (Inflammations) 12/2018 - 03/2016
3	Coxsackievirus Infections 09/2017 - 10/2015
2	Cardiomyopathies (Cardiomyopathy) 09/2017 - 10/2015
2	Ovarian Neoplasms (Ovarian Cancer) 01/2017 - 04/2012
1	Poliomyelitis (Polio) 01/2021
1	Foot and Mouth Disease Hand (Hand, Foot, Mouth Disease) 01/2021
1	Bacterial Infections (Bacterial Infection) 01/2021
1	Gliosis 12/2018
1	Heart Diseases (Heart Disease) 09/2017
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2017
1	Breast Neoplasms (Breast Cancer) 01/2017
1	Diabetic Cardiomyopathies 03/2016
1	Miyoshi myopathy 10/2015
1	type 2B Limb-girdle muscular dystrophy 10/2015
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 10/2015
1	Picornaviridae Infections 07/2015
1	Leukemia 04/2012
1	Lymphoma (Lymphomas) 10/2011
1	B-Cell Lymphoma (Lymphoma, B Cell) 10/2011
1	Cardiotoxicity 10/2011

Drug/Important Bio-Agent (IBA)

6	Antiviral Agents (Antivirals)IBA 01/2021 - 07/2013
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 07/2013
5	Peptide Hydrolases (Proteases)FDA Link 01/2019 - 10/2013
3	Viral RNAIBA 01/2021 - 07/2013
3	Viral ProteinsIBA 01/2019 - 07/2015
2	Aligeron (AS 2)IBA 01/2019 - 12/2018
2	Small Interfering RNA (siRNA)IBA 01/2019 - 07/2015
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2017 - 04/2012
1	CytokinesIBA 01/2021
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2021
1	Viral ProteasesIBA 01/2021
1	Interferon Type IIBA 01/2021
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2019
1	Neuregulin-1 (Neuregulin 1)IBA 01/2019
1	nuclear pore complex protein 98IBA 01/2019
1	NLR ProteinsIBA 01/2019
1	Presenilin-1IBA 01/2019
1	InflammasomesIBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 12/2018
1	UbiquitinIBA 12/2018
1	DNA-Binding Proteins (DNA Binding Protein)IBA 12/2018
1	Monoclonal AntibodiesIBA 11/2018
1	DesminIBA 09/2017
1	Crystallins (Crystallin)IBA 09/2017
1	Protein AggregatesIBA 09/2017
1	Molecular Chaperones (Chaperone, Molecular)IBA 09/2017
1	Carrier Proteins (Binding Protein)IBA 01/2017
1	mangiferinIBA 03/2016
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 03/2016
1	Hypoglycemic Agents (Hypoglycemics)IBA 03/2016
1	Streptozocin (Streptozotocin)FDA Link 03/2016
1	Advanced Glycation End ProductsIBA 03/2016
1	Immunoconjugates (Immunoconjugate)IBA 01/2016
1	CaspasesIBA 11/2015
1	DysferlinIBA 10/2015
1	Internal Ribosome Entry SitesIBA 07/2015
1	Heterogeneous-Nuclear Ribonucleoprotein Group MIBA 07/2015
1	RibonucleoproteinsIBA 09/2014
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 10/2013
1	Poly AIBA 01/2013
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 04/2012
1	Cholic AcidsIBA 04/2012
1	Peptides (Polypeptides)IBA 04/2012
1	IntegrinsIBA 04/2012
1	MicellesIBA 10/2011
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 10/2011
1	EnzymesIBA 10/2011
1	Pharmaceutical PreparationsIBA 10/2011
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2011
1	Creatine Kinase (Creatine Phosphokinase)IBA 10/2011
1	AcidsIBA 10/2011

Therapy/Procedure

1	Therapeutics 01/2016